FIT Clinical Trials

70 recruitingLast updated: June 18, 2026

There are 70 actively recruiting fit clinical trials across 30 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 1, Phase 4. Top locations include Taipei, Taiwan, Miami, Florida, United States, Hangzhou, Zhejiang, China. Updated daily from ClinicalTrials.gov.


FIT Trials at a Glance

70 actively recruiting trials for fit are listed on ClinicalTrialsFinder across 6 cities in 30 countries. The largest study group is Not Applicable with 42 trials, with the heaviest enrollment activity in Taipei, Miami, and Hangzhou. Lead sponsors running fit studies include Duke University, Cairo University, and First Affiliated Hospital of Zhejiang University.

Browse fit trials by phase

Treatments under study

About FIT Clinical Trials

Looking for clinical trials for FIT? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new FIT trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about FIT clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 70 trials

Recruiting
Not Applicable

Evaluating Health Outcomes of AI-Based Fitness Wearables and App Programs in Older Adults Living Alone With Cognitive Decline

Older AdultsPhysical InactivityPhysical Activity+4 more
The University of Tennessee, Knoxville64 enrolled2 locationsNCT07207993
Recruiting
Not Applicable

Refitting Satisfied INFUSE One-Day Multifocal Wearers to DAILIES TOTAL1 Multifocal Contact Lenses

PresbyopiaContact Lens Comfort and Successful Refitting
Gordon Schanzlin New Vision30 enrolled1 locationNCT07638943
Recruiting
Not Applicable

Effects of Blood Flow Restriction Training on Body Composition and Maximal Strength in Military Personnel

Body CompositionMuscle StrengthPhysical Fitness
Yang Liu36 enrolled1 locationNCT07628478
Recruiting
Not Applicable

REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19

Cardiorespiratory FitnessICU acquired weaknessCOVID-19+2 more
Duke University120 enrolled5 locationsNCT05218083
Recruiting
Phase 2

Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Patients - WINDOW-4 Study

RituximabMCLBTKi+2 more
M.D. Anderson Cancer Center30 enrolled1 locationNCT07257055
Recruiting

IMMUNO-FIT Observational Study

Quality of LifeNeoplasmsImmunotherapy+2 more
University Hospital Southampton NHS Foundation Trust67 enrolled1 locationNCT07354971
Recruiting
Not Applicable

Development & Validation of Preoperative Objective Physiological Evaluation

Cardiorespiratory Fitness
Duke University100 enrolled1 locationNCT05092126
Recruiting
Not Applicable

A Pilot Study to Evaluate the Ability of Lactoferrin to Modulate Iron Homeostasis and Exercise Performance in Exercising Females

Low ferritinIron DeficienciesIron-deficiency+1 more
Lindenwood University30 enrolled1 locationNCT07546591
Recruiting
Not Applicable

"Xuong Tan Lac Than" Exercise for Range of Motion and Muscle Endurance

HealthyPhysical Fitness
University of Medicine and Pharmacy at Ho Chi Minh City34 enrolled1 locationNCT07520071
Recruiting

Can Imaging be an Alternative to Exercise Testing as a Predictor of Surgical Fitness?

ImagingSurgical Fitness
University Hospitals of North Midlands NHS Trust56 enrolled1 locationNCT06544187
Recruiting
Not Applicable

Impact of Training Load on the Gut miCrobiome And Its Relation to exeRcise Performance, mUscle Phenotype, and markerS of Overreaching in Healthy Men

Exercise performanceMetabolic HealthExercise+12 more
Stefan De Smet45 enrolled1 locationNCT07481578
Recruiting
Phase 1Phase 2

Venetoclax Plus Hypomethylating Agents and Subcutaneous Cytarabine for CEBPA-Mutated AML

Acute Myeloid Leukemia (AML)CEBPA MutationUnfit, New-diagnosis AML
The First Affiliated Hospital of Soochow University29 enrolled1 locationNCT07451912
Recruiting
Not Applicable

Aerobic Exercise-induced Effect on Endothelial Function in Patients With Ischaemic Heart Disease

Cardiorespiratory FitnessAcute Myocardial InfarctionAngina, Stable+3 more
Instituto de Investigación Sanitaria y Biomédica de Alicante132 enrolled2 locationsNCT06788275
Recruiting
Not Applicable

Diaphragmatic Kinesio Taping With HIIT in Trained Individuals

Healthy VolunteersPostural BalancePhysical Fitness
Agri Ibrahim Cecen University30 enrolled1 locationNCT07390721
Recruiting
Phase 2

Gilteritinib Plus VA Followed By Consolidation Chemotherapy in Newly Diagnosed FLT3-ITD+ AML

Acute Myeloid LeukemiaIntermediate Risk Acute Myeloid LeukemiaFLT3 Internal Tandem Duplication Positive+1 more
First Affiliated Hospital of Zhejiang University25 enrolled1 locationNCT07259707
Recruiting

Molecular Indicators of Systematic Fitness

AgingHealthy AdultFitness Testing+3 more
VO Health, Inc.250 enrolled1 locationNCT07393841
Recruiting
Phase 2

Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML

Newly Diagnosed Acute Myeloid Leukemia (AML)Intensive Chemotherapy UnfitAge ≥60
First Affiliated Hospital of Zhejiang University25 enrolled5 locationsNCT07172204
Recruiting
Not Applicable

Effects of Wearable Device Functions and Health Coaching on Device-measured Movement Behaviours and Cardiometabolic Risk Factors in Adults With Central Obesity

ExercisePhysical ActivitiesHealth Coaching+2 more
The University of Hong Kong133 enrolled1 locationNCT07379970
Recruiting
Not Applicable

Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis

Cost-Benefit AnalysisDrug Resistant TuberculosisHIV Coinfection
University of California, San Francisco2,500 enrolled1 locationNCT05553236
Recruiting
Not Applicable

Evaluating Whether Hyperbaric Oxygen Therapy Can Improve VO₂-Max and Reduce Inflammation Markers in Healthy Adults Ages 30-60.

cardiovascular fitnessInflammation
University of Texas at Austin30 enrolled2 locationsNCT07361861